Primary Glioblastoma Presenting as Brain Metastasis in ALK-Positive Lung Cancer
Overview
This report details a rare case of primary glioblastoma misdiagnosed as brain metastasis in a patient with ALK-positive lung adenocarcinoma. The case underscores the importance of distinguishing between primary brain tumors and metastases to optimize treatment strategies and improve patient outcomes.
Background
Lung cancer is the leading cause of cancer-related mortality globally, with ALK-positive lung adenocarcinoma patients at high risk for brain metastases. New intracranial lesions in these patients are often assumed to be metastases, which can lead to inappropriate treatment. Recognizing the potential for double primary cancers is crucial for timely and effective management.
Data Highlights
No numerical data available in the article.
Key Findings
['A 63-year-old female with ALK-positive lung adenocarcinoma developed a new brain lesion two years post-surgery.', 'The lesion was initially misdiagnosed as a brain metastasis, leading to inappropriate treatment.', 'Pathological examination confirmed the lesion as primary glioblastoma, indicating a metachronous double primary cancer.', 'The patient experienced progressive symptoms and ultimately died 10 months after the glioblastoma diagnosis.', 'This case highlights the diagnostic challenges in differentiating between brain metastases and primary brain tumors, emphasizing the need for accurate treatment strategies.']
Clinical Implications
Healthcare professionals should maintain a high index of suspicion for second primary cancers in patients with known malignancies presenting with new intracranial lesions. Timely pathological confirmation and a multidisciplinary approach can enhance diagnostic accuracy and treatment efficacy.
Conclusion
This case emphasizes the necessity of vigilance in diagnosing new intracranial lesions in cancer patients, as misdiagnosis can lead to significant delays in appropriate treatment.
